Gilead Sciences

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases.

Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Gilead Sciences, established in 1987 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Communities, Health Care, Wellness, Social, Non Profit, Charity, Humanitarian, Market Research, Education, Universities. The organization boasts a portfolio of 50 investments, with an average round size of $260.4M and 17 successful exits. Their recent investments include San Francisco Community Health Center, Power Safe Place Resource Center of Virginia, National Association of Black Social Workers, Howard University, California Black Women’s Health Project. The highest investment round they participated in was $348.2B. Among their most notable exits are San Francisco Community Health Center and Power Safe Place Resource Center of Virginia. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.